Mimedx (MDXG) Equity Ratio (2010 - 2026)

Mimedx has disclosed Equity Ratio across 17 years of filings, most recently posting 0.79 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.79, up 4.96% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.79 (up 4.96% YoY), and the FY2025 annual result was 0.75, up 2.32% from the prior year.
• Equity Ratio came in at 0.79 for Q1 2026 at Mimedx, up from 0.75 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.79 in Q1 2026 to a low of 0.11 in Q3 2022.
• The 5-year median for Equity Ratio is 0.7 (2024), against an average of 0.4.
• Across the five-year window, Equity Ratio tumbled 24147.84% in 2022 and jumped 10447.82% in 2024, its largest moves.
• Mimedx's Equity Ratio stood at 0.1 in 2022, then soared by 668.98% to 0.6 in 2023, then grew by 22.56% to 0.73 in 2024, then climbed by 2.32% to 0.75 in 2025, then climbed by 5.12% to 0.79 in 2026.
• The last three Equity Ratio figures came in at 0.79 (Q1 2026), 0.75 (Q4 2025), and 0.75 (Q3 2025), per Business Quant data.